Avior Bio, Inc.
PrivateLast Round
Debt
Nov 1, 2022
Total Funding Raised
$2.76M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avior Bio, Inc. operates in Healthcare & Life Sciences and is based in Cary, North Carolina. Its latest recorded funding round was a Debt round in November 2022.
Avior Bio, Inc. is a pharmaceutical company that develops drug delivery technology and therapeutic treatments for neurological conditions and pruritus.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avior Bio, Inc. Comparables
Compare Avior Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CURE Pharmaceutical | 82% | |
| Rapid Dose Therapeutics Corp. | 78% | |
| Aavishkar Oral Strips | 77% |
For institutional investors. Book with your work email.
Avior Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Nov 1, 2022 | ||||
| Grant | Jul 1, 2021 | ||||
| Seed | Feb 22, 2021 | ||||
| Debt | Nov 1, 2020 | ||||
| Debt | Jul 28, 2020 | ||||
Pre Seed | Jul 28, 2020 |
For institutional investors. Book with your work email.
Avior Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| North Carolina Biotechnology Center | Debt |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 40% MoM.
- Jul 24, 2026
Monthly visitors grew 266% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
Avior Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avior Bio, Inc.'s valuation, stock price, and market status.
Is Avior Bio, Inc. a public or private company?
Avior Bio, Inc. is a private company.
What is the current stock price of Avior Bio, Inc.?
Avior Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Avior Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avior Bio, Inc. worth (valuation)?
Valuation information for Avior Bio, Inc. is not publicly available.
Can I buy Avior Bio, Inc. stock?
Avior Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avior Bio, Inc.'s last funding round?
Avior Bio, Inc.'s most recent funding round was Debt on November 1, 2022.
Who are the main investors in Avior Bio, Inc.?
Key investors in Avior Bio, Inc. include National Institute on Drug Abuse, North Carolina Biotechnology Center, National Institutes of Health (NIH), National Science Foundation.
Will Avior Bio, Inc. IPO soon?
No public IPO plans have been announced for Avior Bio, Inc..
How can I track Avior Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Avior Bio, Inc.'s shares on secondary markets.